CLEAR CELL RENAL CELL CANCER (CCRCC)
Clinical trials for CLEAR CELL RENAL CELL CANCER (CCRCC) explained in plain language.
Never miss a new study
Get alerted when new CLEAR CELL RENAL CELL CANCER (CCRCC) trials appear
Sign up with your email to follow new studies for CLEAR CELL RENAL CELL CANCER (CCRCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new drug called GI-101, either alone or with pembrolizumab or lenvatinib, in people with advanced solid tumors (cancers that have spread). The goal is to see if it is safe and works against the cancer. About 317 adults with certain cancers like lung, kidney, or…
Matched conditions: CLEAR CELL RENAL CELL CANCER (CCRCC)
Phase: PHASE1, PHASE2 • Sponsor: GI Innovation, Inc. • Aim: Disease control
Last updated May 17, 2026 06:50 UTC
-
New radiation drug shows promise for Hard-to-Treat kidney cancer
Disease control Recruiting nowThis study tests a new drug, 177Lu-TLX250, which delivers radiation directly to kidney cancer cells. It is for adults with advanced clear cell renal cell carcinoma that has come back or spread. The trial compares two different doses of the drug to standard single-drug therapy to …
Matched conditions: CLEAR CELL RENAL CELL CANCER (CCRCC)
Phase: PHASE3 • Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New radiation therapy targets Hard-to-Treat cancers
Disease control Recruiting nowThis study is testing a new treatment that delivers radiation directly to cancer cells in people with advanced solid tumors that cannot be removed by surgery. The treatment uses a special molecule to find and attach to cancer cells, then delivers a radioactive payload to destroy …
Matched conditions: CLEAR CELL RENAL CELL CANCER (CCRCC)
Phase: PHASE1, PHASE2 • Sponsor: ITM Oncologics GmbH • Aim: Disease control
Last updated May 11, 2026 20:47 UTC
-
New imaging agent could sharpen cancer detection
Diagnosis Recruiting nowThis study is testing a new type of PET/CT scan that uses a special tracer called 18F-T2 to find cancers that have high levels of a protein called CAIX. About 200 adults with cancers like kidney, bladder, lung, or breast cancer will get this scan to see if it works better than th…
Matched conditions: CLEAR CELL RENAL CELL CANCER (CCRCC)
Phase: NA • Sponsor: Peking University First Hospital • Aim: Diagnosis
Last updated May 17, 2026 06:52 UTC